Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Angelika Gawlik"'
Autor:
Dawid Sigorski, Michał Wilk, Angelika Gawlik-Urban, Agata Sałek-Zań, Joanna Kiszka, Mateusz Malik, Katarzyna Czerko, Kamil Kuć, Cezary Szczylik, Tomasz Kubiatowski, Bożena Cybulska-Stopa, Emilia Filipczyk-Cisarż, Lubomir Bodnar, Iwona Skoneczna
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundAbiraterone acetate (ABI) and Enzalutamide (ENZA) are second-generation hormone drugs that show breakthrough activity in post-chemotherapy, metastatic castration-resistant prostate cancer (mCRPC). The leading oncological and urological guid
Externí odkaz:
https://doaj.org/article/f594f2ec3db6467d86a545074763cad2
Autor:
Anna Brodziak, Dawid Sigorski, Małgorzata Osmola, Michał Wilk, Angelika Gawlik-Urban, Joanna Kiszka, Katarzyna Machulska-Ciuraj, Paweł Sobczuk
Publikováno v:
Vaccines, Vol 9, Iss 5, p 411 (2021)
Recently developed COVID-19 vaccines significantly reduce the risk of severe coronavirus disease, which is essential in the particularly vulnerable cancer patient population. There is a growing anti-vaccine concern that may affect the success of the
Externí odkaz:
https://doaj.org/article/16d8c4918e9d448dabbb54ecc80a46cb
Autor:
Michal Wilk, Joanna Kiszka, Angelika Gawlik-Urban, Paweł Sobczuk, Małgorzata Osmola, Dawid Sigorski, Katarzyna Machulska-Ciuraj, Anna Brodziak
Publikováno v:
Vaccines; Volume 9; Issue 5; Pages: 411
Vaccines
Vaccines, Vol 9, Iss 411, p 411 (2021)
Vaccines
Vaccines, Vol 9, Iss 411, p 411 (2021)
Recently developed COVID-19 vaccines significantly reduce the risk of severe coronavirus disease, which is essential in the particularly vulnerable cancer patient population. There is a growing anti-vaccine concern that may affect the success of the
Autor:
Angelika Gawlik, Bogumiła Ciseł, Ewelina Guz, Marek Sokoluk, Kinga Franciszkiewicz-Pietrzak, Witold Krupski, Witold Budny, Konrad Krzyzanowski, Andrzej Kurylcio, Robert Sitarz, Wojciech Polkowski, Jerzy Mielko, Magdalena Skórzewska, Monika Lewicka
Publikováno v:
Nowotwory. Journal of Oncology. 64:129-134
Wstep. Leczenie chirurgiczne przerzutow nowotworow litych do wątroby powinno odbywac sie w ramach zespolu wielodyscyplinarnego. Cel pracy. Celem pracy jest ocena wynikow leczenia skojarzonego chorych na rozne nowotwory lite z przerzutami do wątroby